Sidra Medicine expands cord blood banking for future stem-cell therapies

Sidra Medicine is opening new frontiers in stem-cell preservation and regenerative medicine with Qatar's first Good Manufacturing Practice (GMP) facility, enabling families to bank cord blood and birth-related tissues locally rather than sending them overseas, while laying the groundwork for potential future cell-based therapies. In an exclusive interview with Gulf Times, Dr Chiara Cugno, Acting…